NCT00272688View on ClinicalTrials.gov

Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Parkinson Disease
Interventions
DRUG

Levodopa (drug), intraduodenal administration

Trial Locations (2)

1474

Akershus University Hospital, Nordbyhagen

0450

Dept Neurology, Ulleval University Hospital, Oslo

All Listed Sponsors
collaborator

Solvay Pharmaceuticals

INDUSTRY

lead

University Hospital, Akershus

OTHER

NCT00272688 - Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit | Biotech Hunter | Biotech Hunter